Pricing Log in Create free account

Biofrontera Inc. (BFRI) vs Incannex Healthcare Inc. (IXHL)

Biofrontera Inc. and Incannex Healthcare Inc. are both Drug Manufacturers Specialty & Generic companies. Incannex Healthcare Inc. is the larger, with a market value of $28.5M against $12.0M — 2.4× the size. Incannex Healthcare Inc. has the higher net margin (0.00% vs −13.8%) and the higher return on invested capital (0.00% vs −69.5%). Across the 17 metrics below, Incannex Healthcare Inc. leads on 11 and Biofrontera Inc. on 6.

Valuation

Metric BFRI IXHL Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 0.23 16.88 2.08
P/B 1.78 0.39 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m 1.65 12.22
EV/Sales 0.23 (24.08) 2.87
Earnings yield (72.84%) (75.75%) (15.94%)
Free cash flow yield (74.83%) (48.87%) 0.00%

Profitability

Metric BFRI IXHL Drug Manufacturers Specialty & Generic median
Gross margin 79.25% (0.10%) 53.51%
Operating margin (14.22%) 0.00% 0.00%
Net margin (13.78%) 0.00% (2.45%)
Free cash flow margin (17.17%) 0.00% 0.00%
Return on equity (988.35%) (47.80%) (0.80%)
Return on assets (28.80%) (41.32%) (1.67%)
Return on invested capital (69.45%) 0.00% 0.00%

Growth

Metric BFRI IXHL Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 17.83% — 5.22%
EPS growth (last fiscal year) 67.70% 95.91% 42.91%
Revenue growth, 5-year CAGR 17.21% (29.64%) 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BFRI IXHL Drug Manufacturers Specialty & Generic median
Debt to equity 0.78 0.00 0.04
Current ratio 1.18 48.81 2.41
Net debt to EBITDA 0.17 2.97 1.01

Dividend

Metric BFRI IXHL Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric BFRI IXHL Drug Manufacturers Specialty & Generic median
Market cap 11.99m 28.47m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack